New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
06:24 EDTGEVASynageva upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Synageva as it believes the company will exit this week's WORLD meeting with strong momentum. The firm raised its price target for shares to $110 from $60.
News For GEVA From The Last 14 Days
Check below for free stories on GEVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 22, 2014
07:07 EDTGEVASynageva appoints Robert Bazemore as COO
Synageva announced the appointment of Robert Bazemore as Chief Operating Officer. Bazemore will oversee the planned global commercial launch of the company's lead program, sebelipase alfa for LAL Deficiency, and will have responsibility for the company's global commercial, market access and medical affairs operations. Bazemore last served at Johnson & Johnson (JNJ) in varoius roles including Vice President, Ethicon New Growth Platforms and President of Janssen Biotech, a part of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use